Raven Jaeger

Consigliere Generale presso CALCIMEDICA, INC.

46 anni

Health Technology

Consumer Services

Profilo

Raven D.
Jaeger is currently the Chief Regulatory Officer at CalciMedica, Inc. Prior to this, she held the position of Director-Regulatory Affairs at Leadiant Biosciences, Inc. from 2011 to 2018.
In 2022, she served as the Chief Regulatory Officer at Diffusion Pharmaceuticals, Inc. Ms. Jaeger also worked as the Senior Vice President-Regulatory Affairs at BridgeBio Pharma, Inc. Ms. Jaeger completed her undergraduate degree at The Johns Hopkins University and her graduate degree at the University of Maryland.

Posizioni attive di Raven Jaeger

Società	Posizione	Inizio
CALCIMEDICA, INC.	Consigliere Generale	23/05/2023

Tutte le posizioni attive di Raven Jaeger

Precedenti posizioni note di Raven Jaeger

Società	Posizione	Fine
DIFFUSION PHARMA	Consigliere Generale	01/03/2023
Leadiant Biosciences, Inc. Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	01/04/2018
BRIDGEBIO PHARMA, INC.	Consigliere Generale	-

Vedi nel dettaglio l'esperienza di Raven Jaeger

Formazione di Raven Jaeger

The Johns Hopkins University	Undergraduate Degree
University of Maryland	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Raven Jaeger

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BRIDGEBIO PHARMA, INC.	Health Technology
CALCIMEDICA, INC.	Health Technology

Aziende private	2
Diffusion Pharmaceuticals, Inc. Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.	Health Technology
Leadiant Biosciences, Inc. Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD.	Health Technology